Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany

Mark E. Westman; Juliana Giselbrecht; Jacqueline M. Norris; Richard Malik; Jennifer Green; Elle Burton-Bradley; Ashley Cheang; Theres Meili; Marina L. Meli; Katrin Hartmann; Regina Hofmann-Lehmann

doi:10.3390/v15020491

Viruses (Feb 2023)

Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany

Mark E. Westman,
Juliana Giselbrecht,
Jacqueline M. Norris,
Richard Malik,
Jennifer Green,
Elle Burton-Bradley,
Ashley Cheang,
Theres Meili,
Marina L. Meli,
Katrin Hartmann,
Regina Hofmann-Lehmann

Affiliations

Mark E. Westman: Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
Juliana Giselbrecht: Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany
Jacqueline M. Norris: Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
Richard Malik: Centre for Veterinary Education, The University of Sydney, Sydney, NSW 2006, Australia
Jennifer Green: Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
Elle Burton-Bradley: Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
Ashley Cheang: Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
Theres Meili: Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
Marina L. Meli: Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
Katrin Hartmann: Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany
Regina Hofmann-Lehmann: Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland

DOI: https://doi.org/10.3390/v15020491
Journal volume & issue: Vol. 15, no. 2
p. 491

Abstract

Read online

Different feline leukemia virus (FeLV) infection outcomes are possible in cats following natural exposure, such as progressive infections (persistent viremia), regressive infections (transient or no viremia followed by proviral persistence) and abortive infections (presence of only antibodies). Laboratory-based testing is currently required for categorization of infection outcomes in cats. The aim of this study was to evaluate the field performance of a novel, rapid, combination point-of-care (PoC) test kit commercially available in Europe (v-RetroFel®Ag/Ab; 2020–2021 version) to determine different FeLV infection outcomes by concurrent detection of FeLV antigen (p27) and antibodies against FeLV transmembrane envelope protein (p15E). A secondary aim was to evaluate the performance of the same test kit (v-RetroFel®FIV) to determine positive/negative feline immunodeficiency virus (FIV) infection status by the detection of antibodies to FIV capsid protein (p24) and transmembrane glycoprotein (gp40). Two cohorts of domestic cats were recruited and tested with v-RetroFel® using plasma or serum, including cats in Australia (n = 200) and cats in Germany (n = 170). Results from p27 antigen PoC testing, proviral DNA PCR, and neutralizing antibody testing or testing for antibodies against non-glycosylated surface unit envelope protein (p45) were used to assign cats to groups according to different FeLV infection outcomes. Testing with a laboratory-based FeLV p15E antibody ELISA was also performed for comparison. In the first cohort, v-RetroFel®Ag/Ab correctly identified 89% (109/122) FeLV-unexposed cats and 91% (21/23) progressive infections, but no regressive (0/23) or abortive (0/32) infections. In the second cohort, v-RetroFel®Ag/Ab correctly identified 94% (148/158) FeLV-unexposed cats and 100% (4/4) progressive infections, but no regressive (0/2) and only 17% (1/6) abortive infections. There was test agreement between v-RetroFel®Ab and the p15E laboratory ELISA in 58.9% of samples. As a secondary outcome of this study, the sensitivity and specificity of v-RetroFel®FIV testing in cohort 1 were 94.7% (18/19) and 98.3% (178/181), and in cohort 2, 30.0% (3/10) and 100.0% (160/160), respectively. Prior history of FIV vaccination did not produce any false-positive FIV results. In conclusion, v-RetroFel®Ag/Ab (2020–2021 version) was unable to accurately determine different FeLV infection outcomes in the field. Improvements of the test prior to application to field samples are required.

Published in Viruses

ISSN: 1999-4915 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Microbiology
Website: http://www.mdpi.com/journal/viruses

About the journal

Abstract

Keywords